Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2007
11/29/2007CA2652694A1 Aerosol formulation containing ipratropium bromide and salbutamol sulfate
11/29/2007CA2652689A1 Method of constructing gene transport support
11/29/2007CA2652662A1 Method for the treatment and prevention of ocular disorders
11/29/2007CA2652656A1 High-molecular weight conjugate of podophyllotoxins
11/29/2007CA2652634A1 Certain substituted quinolones, compositions, and uses thereof
11/29/2007CA2652617A1 Flavonoid dimers and methods of making and using such
11/29/2007CA2652600A1 Use of cathepsin k antagonists in bone production
11/29/2007CA2652590A1 Ruthenium ii compounds
11/29/2007CA2652576A1 Methods and compositions for the treatment of viral infections
11/29/2007CA2652573A1 Unit dose formulations comprising an inhalable solution of albuterol
11/29/2007CA2652559A1 Biotherapeutic compositions and uses thereof
11/29/2007CA2652539A1 Oligonucleotides affecting expression of phosphodiesterases
11/29/2007CA2652537A1 Veterinary pharmaceutical compositions for the treatment of pain and inflammation
11/29/2007CA2652484A1 Heterocyclic type cinnamide derivative
11/29/2007CA2652469A1 Piperidine derivatives as human papilloma virus inhibitors
11/29/2007CA2652449A1 Screening methods for amyloid beta modulators
11/29/2007CA2652443A1 1- [ (4- [benzoyl (methyl) amino] -3- (phenyl) butyl] azetidine derivatives for the treatment of gastrointestinal disorders 1
11/29/2007CA2652442A1 Antitumor agent for thyroid cancer
11/29/2007CA2652416A1 Treatment for depressive disorders
11/29/2007CA2652408A1 Means and method for inducing exon-skipping
11/29/2007CA2652399A1 Novel compounds
11/29/2007CA2652394A1 Triazole derivatives ii
11/29/2007CA2652393A1 1,5-diphenylpyrazoles ii as hsp90 inhibitors
11/29/2007CA2652375A1 Heterocyclic inhibitors of 11-.beta. hydroxyl steroid dehydrogenase type i and methods of using the same
11/29/2007CA2652367A1 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
11/29/2007CA2652361A1 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same
11/29/2007CA2652251A1 Compositions of r(+) and s(-) pramipexole and methods for using the same
11/29/2007CA2652238A1 Phenanthrene derivatives as mpges-1 inhibitors
11/29/2007CA2652117A1 Therapeutic fluoroethyl ureas
11/29/2007CA2652061A1 Pyrimidine low molecular weight ligands for modulating hormone receptors
11/29/2007CA2652040A1 Prostaglandin transporter inhibitors
11/29/2007CA2652038A1 Methods for preventing or treating acute and chronic pain
11/29/2007CA2651777A1 Pro-drugs of tertiary alcohols
11/29/2007CA2651769A1 Thiazolo-pyramidine / pyridine urea derivatives as adenosine a2b receptor antagonists
11/29/2007CA2651762A1 Compounds and compositions as channel activating protease inhibitors
11/29/2007CA2651700A1 Cyclic amine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
11/29/2007CA2651690A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
11/29/2007CA2651681A1 Aryl-fused spirocyclic compounds
11/29/2007CA2651677A1 2-arylpyrazolo[l,5-.alpha.]pyrimidin-3-yl acetamide derivatives as ligands for translocator protein (18 kda)
11/29/2007CA2651607A1 Mirtazapine for the treatment of neuropathic pain
11/29/2007CA2651598A1 Compounds for the treatment of metabolic disorders
11/29/2007CA2651487A1 Methods for treating chemotherapy and radiation therapy side effects
11/29/2007CA2651451A1 Extended release oral multimicroparticle dosage form
11/29/2007CA2651420A1 Spiro tetracyclic compound
11/29/2007CA2651411A1 39-desmethoxy-39-methyl derivatives of rapamycin
11/29/2007CA2651405A1 36 -des (3 -methoxy-4 -hydroxycyclohexyl) 36 - (3 -hydroxycycloheptyl) derivatives of rapamycin for the treatment of cancer and other disorders
11/29/2007CA2651396A1 Urea type cinnamide derivative
11/29/2007CA2651395A1 Phosphorous containing compounds including triphenylmethylphosphonate esters for the treatment of melanoma and other cancers
11/29/2007CA2651153A1 Antidiabetic bicyclic compounds
11/29/2007CA2651134A1 Indole derivatives and their use as thyroid receptor ligands
11/29/2007CA2650916A1 Crystalline forms of 5-chloro-6-(2,6-difluoro-4-[3-(methylamino)propoxy]phenyl)-n-[(1s)-2,2,2-trifluoro-1-methylethyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine salts
11/29/2007CA2650813A1 New long-acting drug combinations for the treatment of respiratory diseases
11/29/2007CA2650661A1 Pyrazolo [3, 4-d] pyrimidine derivatives useful to treat respiratory disorders
11/29/2007CA2650655A1 5-phenyl-thiaz0l-2-yl-urea derivatives and use as pi3 kinase inhibitors
11/29/2007CA2650624A1 Compositions and methods for enhancing mineral levels in animals with reduced environmental impact
11/29/2007CA2650619A1 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
11/29/2007CA2650611A1 Compositions and methods for fgf receptor kinases inhibitors
11/29/2007CA2650416A1 Rnai-mediated inhibition of tumor necrosis factor .alpha.-related conditions
11/29/2007CA2649913A1 N-benzoyl- and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists
11/29/2007CA2649810A1 Cladribine regimen for treating multiple sclerosis
11/29/2007CA2649794A1 (2r)-2-[(4-sulfonyl)aminophenyl] propanamides and pharmaceutical compositions containing them
11/29/2007CA2649707A1 Substituted pyrazinone derivatives for use as a medicine
11/29/2007CA2649685A1 Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation et utilisation connexes, et compositions contenant lesdits derives
11/29/2007CA2649336A1 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof, and compositions containing the same
11/29/2007CA2649224A1 Thiazolidinedione derivatives as pi3 kinase inhibitors
11/29/2007CA2648946A1 Use of a composition consisting of a combination of hydroquinone, fluocinolone acetonide and tretinoin, intended for treatment signs of photoaging of the skin
11/29/2007CA2647830A1 Central nervous system active fused bicycloheterocycle substituted azabicyclic alkane derivatives
11/29/2007CA2647563A1 Personal care compositions
11/29/2007CA2646186A1 Small molecule apoptosis promoters
11/29/2007CA2646081A1 Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor
11/29/2007CA2646076A1 3-pyraz0lyl-benzamide-4-ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
11/28/2007EP1860192A1 Compositions and methods for treating intracellular diseases
11/28/2007EP1860118A2 Immunoadhesin comprising a glycoprotein VI domain
11/28/2007EP1860115A1 Oligonucleotide derivative, probe for detection of gene, and dna chip
11/28/2007EP1860114A1 Nitroguanosine-3 ,5 -cyclic monophosphate and protein kinase g activator
11/28/2007EP1860113A1 Ectonucleotidase inhibitors
11/28/2007EP1860110A1 Cyclodextrins functionalised with etodolac as specific site release agents
11/28/2007EP1860109A1 Azetidine amino pyrimidine compounds for the treatment of inflammatory disorders
11/28/2007EP1860108A1 Enantiomers of Amino Pyrimidine compounds for the treatment of inflammatory disorders
11/28/2007EP1860107A1 Photosensitive compound
11/28/2007EP1860106A1 Tricyclic thrombin receptor antagonists
11/28/2007EP1860104A1 Anti-proliferative compounds deriving from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and uses thereof
11/28/2007EP1860103A1 Anticancer compound, intermediate therefor, and processes for producing these
11/28/2007EP1860101A1 Tartrate sale of isofagomine and methods of use
11/28/2007EP1860100A2 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI
11/28/2007EP1860098A1 Novel anthranilic acid derivative or salt thereof
11/28/2007EP1859835A2 Topical agent for dermatological use containing 4-hydroxyphenyl-alpha-D-glucopyranoside
11/28/2007EP1859834A1 Anti-inflammatory agent
11/28/2007EP1859808A1 Novel sugar uptake activator and method for screening the same
11/28/2007EP1859807A1 Recurrence preventive therapeutic agent for psychostimulant-induced psychosis and schizophrenia
11/28/2007EP1859806A1 Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigen
11/28/2007EP1859804A1 Anticancer agent to be combined with telomelysin
11/28/2007EP1859803A1 Promoter for hard tissue formation
11/28/2007EP1859802A2 Compositions comprising benzo(G)quinoline derivates and prostaglandin derivates
11/28/2007EP1859801A1 Therapeutic agent and prophylactic agent for endometriosis and adenomyosis uteri
11/28/2007EP1859800A1 Medicament comprising alkyl esters of imidazole carboxylic acid for the treatment of neurodegenerative disorders
11/28/2007EP1859799A1 Novel PPAR ligands that do not cause fluid retention, edema or congestive heart failure
11/28/2007EP1859798A1 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
11/28/2007EP1859797A1 Novel concomitant use of sulfonamide compound with anti-cancer agent
11/28/2007EP1859796A2 Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
1 ... 3483 3484 3485 3486 3487 3488 3489 3490 3491 3492 3493 3494 3495 3496 3497 3498 3499 3500 3501 3502 3503 ... 7860